Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 19;69(24):735-739.
doi: 10.15585/mmwr.mm6924a2.

Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020

Lucy A McNamara, Caelin Potts, Amy E Blain, Adam C Retchless, Natashia Reese, Stephanie Swint, David Lonsway, Maria Karlsson, Kristy Lunquest, John J Sweitzer, Xin Wang, Susan Hariri, LeAnne M Fox; Antimicrobial-Resistant Neisseria meningitidis Team
Collaborators, Affiliations

Detection of Ciprofloxacin-Resistant, β-Lactamase-Producing Neisseria meningitidis Serogroup Y Isolates - United States, 2019-2020

Lucy A McNamara et al. MMWR Morb Mortal Wkly Rep. .

Abstract

Meningococcal disease is a sudden-onset, life-threatening illness caused by the bacterium Neisseria meningitidis. Prompt empiric antibiotic treatment can reduce morbidity and mortality among patients, and antibiotic prophylaxis can prevent secondary disease in close contacts. Historically, N. meningitidis isolates in the United States have largely been susceptible to the antibiotics recommended for treatment and prophylaxis, including penicillin and ciprofloxacin. This report describes detection of penicillin-resistant and ciprofloxacin-resistant N. meningitidis serogroup Y (NmY) isolates in the United States. NmY isolates containing a blaROB-1 β-lactamase enzyme gene conferring resistance to penicillins (1) were recovered from 33 cases reported during 2013-2020. Isolates from 11 of these cases, reported during 2019-2020, harbored a ciprofloxacin resistance-associated mutation in a chromosomal gene (gyrA). Cases were reported from 12 geographically disparate states; a majority of cases (22 of 33, 67%) occurred in Hispanic persons. These cases represent a substantial increase in penicillin-resistant and ciprofloxacin-resistant meningococci in the United States since 2013. Ceftriaxone and cefotaxime, the recommended first-line agents for empiric bacterial meningitis treatment, can continue to be used for treatment, but health care providers should ascertain susceptibility of meningococcal isolates to penicillin before switching to penicillin or ampicillin. Ongoing monitoring for antimicrobial resistance among meningococcal isolates and prophylaxis failures will be important to inform treatment and prophylaxis recommendations.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Figures

FIGURE 1
FIGURE 1
Clonal complex 23 Neisseria meningitidis isolates (N = 33) with a blaROB-1 β-lactamase enzyme gene alone or in combination with a ciprofloxacin resistance–associated mutation (cipro-R), by quarter — United States, 2013–2020 * Conferring resistance to penicillins.
FIGURE 2
FIGURE 2
Meningococcal disease cases with clonal complex 23 Neisseria meningitidis isolates (N = 33) with a blaROB-1 β-lactamase enzyme gene alone or in combination with a ciprofloxacin resistance–associated mutation, by state — United States, 2013–2020 Abbreviation: DC = District of Columbia. * Conferring resistance to penicillins.
See this image and copyright information in PMC

References

    1. San Millan A, Escudero JA, Catalan A, et al. β-lactam resistance in Haemophilus parasuis is mediated by plasmid pB1000 bearing blaROB-1. Antimicrob Agents Chemother 2007;51:2260–4. 10.1128/AAC.00242-07 - DOI - PMC - PubMed
    1. Meningococcal infections. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red book: 2018–2021 report of the committee on infectious diseases, 31st edition. Itasca, IL: American Academy of Pediatrics; 2018. https://redbook.solutions.aap.org/chapter.aspx?sectionid=189640131&booki...
    1. Cohn AC, MacNeil JR, Clark TA, et al.; CDC. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013;62(No. RR-2). - PubMed
    1. McNamara LA, Blain A. Meningococcal disease. In: Roush SW, Baldy LM, Hall MAK, eds. Manual for the surveillance of vaccine-preventable diseases. Atlanta, GA: US Department of Health and Human Services, CDC; 2019. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt08-mening.html
    1. Harcourt BH, Anderson RD, Wu HM, et al. Population-based surveillance of Neisseria meningitidis antimicrobial resistance in the United States. Open Forum Infect Dis 2015;2:ofv117. 10.1093/ofid/ofv117 - DOI - PMC - PubMed